Literature DB >> 11278691

Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.

B Belletti1, M Prisco, A Morrione, B Valentinis, M Navarro, R Baserga.   

Abstract

The Id proteins play an important role in proliferation, differentiation, and tumor development. We report here that Id gene expression can be regulated by the insulin-like growth factor I receptor (IGF-IR), a receptor that also participates in the regulation of cellular proliferation and differentiation. Specifically, we found that the IGF-IR activated by its ligand was a strong inducer of Id2 gene expression in 32D murine hemopoietic cells. This activation was not simply the result of cellular proliferation, as Id2 gene expression was higher in 32D cells stimulated by IGF-I than in cells exponentially growing in interleukin-3. The up-regulation of Id2 gene expression was largely dependent on the presence of insulin receptor substrate-1, a major substrate of the IGF-IR and a potent activator of the phosphatidylinositol 3-kinase (PI3K) pathway. The role of PI3K activity in the up-regulation of Id2 gene expression by the IGF-IR was confirmed by different methods and in different cell types. In 32D cells, the up-regulation of Id2 gene expression by the PI3K pathway correlated with interleukin-3 independence and inhibition of differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278691     DOI: 10.1074/jbc.M010509200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 2.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

3.  Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation.

Authors:  Ning Wu; David Castel; Marie-Anne Debily; Maria Alessandra Vigano; Olivier Alibert; Roberto Mantovani; Kristina Iljin; Paul-Henri Romeo; Xavier Gidrol
Journal:  J Biol Chem       Date:  2011-04-10       Impact factor: 5.157

4.  Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal.

Authors:  Raphael Rubin; Alla Arzumanyan; Angela Rachele Soliera; Brian Ross; Francesca Peruzzi; Marco Prisco
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

5.  Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.

Authors:  Marco Prisco; Arianna Maiorana; Clara Guerzoni; George Calin; Bruno Calabretta; Renate Voit; Ingrid Grummt; Renato Baserga
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.

Authors:  M M J Kool; S Galac; N van der Helm; S Corradini; H S Kooistra; J A Mol
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

7.  Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells.

Authors:  Doron Weinstein; Rive Sarfstein; Zvi Laron; Haim Werner
Journal:  Endocr Connect       Date:  2014-01-28       Impact factor: 3.335

8.  GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.

Authors:  Kuan-yu Chen; Chao-chung Chen; Yau-lin Tseng; Yi-chien Chang; Ming-chung Chang
Journal:  Oncotarget       Date:  2014-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.